- Chemohormonal regimen of epirubicin, etoposide, and dexamethasone in patients with hormone-refractory prostate cancer2003 | First Faculty of Medicine
- Bi-weekly epirubicin, etoposide and low-dose dexamethasone for hormone-refractory prostate cancer2003 | First Faculty of Medicine
- Research Report University Hospital for clinical assessment TPU-S1119Publication without faculty affiliation
- Research Report University Hospital for clinical assessment 20070622Publication without faculty affiliation
- Chemohormonal regimen of epirubicin, etoposide, and dexamethasone in patients with hormone-refractory prostate cancer2003 | Faculty of Medicine in Hradec Králové
- Chemohormonal therapy using EED regimen (Epirubicin, Etoposide, Dexamethason) in patients with hormonal-refractory prostate cancer2001 | Faculty of Medicine in Hradec Králové
- Phase I study of orally administered S-1 in combination with epirubicin and oxaliplatin in patients with advanced solid tumors and chemotherapy-naive advanced or metastatic esophagogastric cancer2017 | Publication without faculty affiliation
- News in adjuvant therapy for breast cancer2015 | First Faculty of Medicine
- Neoadjuvant chemotherapy with vinorelbine and epirubicine in locallyPublication without faculty affiliation
- Vinorelbine, epirubicin, and methotrexate (VEM) as primary treatment in locally advanced breast cancer2001 | Second Faculty of Medicine
- Population Pharmacokinetics of Docetaxel, Paclitaxel, Doxorubicin and Epirubicin in Pregnant Women with Cancer: A Study from the International Network of Cancer, Infertility and Pregnancy (INCIP)2021 | Third Faculty of Medicine
- Bi-weekly epirubicin, etoposide and low-dose dexamethasone for hormone-refractory prostate cancer2003 | Faculty of Medicine in Hradec Králové
- Long-term prevention of bladder cancer progression by alpha1-oleate alone or in combination with chemotherapy2023 | Second Faculty of Medicine
- Application of a Micro-Volume Voltammetric Cell for Determination of Doxorubicin Hydrochloride2018 | Faculty of Science, Central Library of Charles University
- A new possible way of anthracycline cytostatics decontamination2017 | First Faculty of Medicine
- Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron2009 | Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
- Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron2009 | Faculty of Medicine in Hradec Králové
- Clinical experience with anthracycline antibiotics-HPMA copolymer-human immunoglobulin conjugates2009 | First Faculty of Medicine
- Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy2015 | Second Faculty of Medicine
- Modulation of Induced Cytotoxicity of Doxorubicin by Using Apoferritin and Liposomal Cages2014 | Faculty of Science
- Re: Long-term Experience with Radiofrequency-induced Hyperthermia Combined with Intravesical Chemotherapy for Non-muscle Invasive Bladder Cancer2022 | Second Faculty of Medicine
- Presentation, Management and Outcome of 32 Patients with Pregnancy-Associated Breast Cancer: A Matched Controlled Study2009 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Prognostic role of early 18-FDG PET/CT during neoadjuvant chemotherapy for resectable adenocarcinoma of the esophagus and esophagogastric junction2021 | First Faculty of Medicine
- Pharmacokinetics of chemotherapeutic agents in pregnancy: a preclinical and clinical study2010 | Publication without faculty affiliation
- Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa-pT1 Urothelial Carcinoma of the Bladder: Which Patients Benefit from the Instillation?2016 | Second Faculty of Medicine
- The efficacy and safety outcomes of lower dose BCG compared to intravesical chemotherapy in non-muscle-invasive bladder cancer: A network meta-analysis2023 | Second Faculty of Medicine